Paxman AB (publ) (PXMBF)
Paxman AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Karlshamn, BL, SE. The stock last traded at $3.50, up 0.00% on the session, giving a market capitalisation of $81.5M. On trailing twelve-month figures it carries a trailing P/E of -96.86, a net margin of -3.2%. Its beta of 0.46 implies it has historically moved less than the broad market.
Paxman AB (publ), operating alongside its subsidiaries, specializes in engineering and marketing the Paxman scalp cooling system. This innovative solution aims to significantly mitigate hair loss experienced by patients undergoing chemotherapy, with its reach extending across a broad international presence including Europe, North America (the United States and Mexico), Asia (Japan and other areas), Oceania, and Central and South America. Its primary clientele consists of oncology clinics and healthcare institutions. The company also maintains a research and development partnership with the National University Hospital in Singapore, focused on creating a mobile cooling and compression apparatus. Founded in 1996, Paxman AB (publ) is headquartered in Karlshamn, Sweden.
Paxman AB (publ) is most often compared with the following Healthcare names: